Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Punita Grover

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 14, 2019
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long StoryRand Naffouje, Punita Grover, Hongyang Yu, et al.
Cancer Medicine|July 11, 2020
COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspectiveMichelle Marcum, Nicky Kurtzweil, Christine Vollmer, et al.
Blood Advances|January 27, 2026
Targeting Aurora Kinase A to Prevent GVHD and Relapse after Myeloablative Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Punita Grover, Kelly Walton, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
JAMA Oncology|November 3, 2022
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19Ziad Bakouny, Chris Labaki, Punita Grover, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 14, 2019
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long StoryRand Naffouje, Punita Grover, Hongyang Yu, et al.
Cancer Medicine|July 11, 2020
COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspectiveMichelle Marcum, Nicky Kurtzweil, Christine Vollmer, et al.
Blood Advances|January 27, 2026
Targeting Aurora Kinase A to Prevent GVHD and Relapse after Myeloablative Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Punita Grover, Kelly Walton, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
The Lancet. Healthy Longevity|February 21, 2022
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer ConsortiumArielle Elkrief, Cassandra Hennessy, Nicole M Kuderer, et al.
JAMA Oncology|November 3, 2022
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19Ziad Bakouny, Chris Labaki, Punita Grover, et al.
Pageof 2